44 results on '"Kusakari, T."'
Search Results
2. General Lectures
- Author
-
Yamaoka, Y., Nagai, T., Furuta, K., Inagawa, T., Sugiya, T., Kai, T., Amamoto, H., Okunara, T., Miyoshi, A., Araya, S., Sometani, T., Ogura, T., Yamato, T., Hirata, S., Hashimoto, T., Hamanaka, Y., Shakudo, Y., Ozaki, T., Noda, S., Kobayashi, K., Sasaki, K., Matsuura, R., Ueno, H., Ito, T., Umayahara, A., Koga, Y., Watanabe, K., Nabeya, K., Shimura, I., Ohyama, O., Komatsuzaki, T., Ogoshi, K., Hara, Y., Hiratsuka, H., Kubo, N., Masuda, H., Inoue, S., Arakawa, H., Koizumi, K., Mukozima, K., Inoue, Y., Hosaka, H., Kikuchi, N., Yoshida, H., Sakumoto, I., Inaba, M., Yokoi, Y., Abei, T., Iwama, S., Shirota, A., Miki, M., Ōkawa, K., Onda, M., Yoshioka, M., Shiba, T., Yamashita, K., Moriyama, Y., Adachi, K., Miyashita, M., Henmi, H., Egami, K., Toi, K., Fukiwake, T., Ito, H., Tamesue, N., Ohsato, K., Nagamitsu, S., Nishimura, M., Yamashita, Y., Yao, T., Mizuno, S., Tanabe, M., Yanase, M., Suzuki, K., Suzuki, K., Hayashi, K., Nishitani, T., Katake, K., Iwasa, N., Nishimura, S., Miyoshi, M., Fukumoto, K., Fujii, H., Inatomi, I., Nakajima, H., Hojo, Y., Tosaka, T., Kaneko, H., Yoshikawa, K., Mori, K., Uematsu, T., Takahashi, T., Morikawa, S., Hashi, M., Sakamoto, T., Kimura, A., Sasagawa, T., Maeda, Y., Matsukawa, M., Aizawa, T., Tabata, I., Munakata, A., Toda, S., Tajima, T., Matsunaga, F., Ogata, T., Nakayama, K., Nakayama, T., Minota, S., Otani, A., Takei, S., Tanaka, M., Miki, H., Hojo, K., Hirota, E., Sano, R., Murashima, Y., Okuuti, Y., Miwa, K., Suga, T., Yaosaka, T., Namiki, M., Kawauti, H., Nakagawa, K., Kasukawa, T., Kobayashi, S., Watanabe, H., Yamagata, S., Narasaka, T., Imai, H., Tsuneoka, T., Watanabe, H., Hoshi, K., Nishiyama, S., Hoshi, K., Fushimi, I., Hirai, T., Katsuda, M., Hirose, M., Yokomori, H., Matsumoto, T., Watanabe, N., Matsuura, K., Ishibashi, T., Nakata, S., Takei, C., Asano, H., Miyoshi, H., Hidaka, T., Dodo, H., Kitada, A., Nakamura, T., Sakata, S., Kitamura, S., Nakamua, T., Sakata, S., Kitamura, S., Agata, E., Aikawa, K., Oshima, A., Fujimoto, I., Kobayashi, T., Asakawa, Y., Kusakari, M., Abe, C., Tarumi, S., Yamashita, T., Takasu, S., Komase, Y., Hamada, H., Shoji, F., Saito, S., Takayama, T., Fujita, R., Kumura, F., Umeda, K., Okamoto, S., Nishio, H., Shintani, Y., Saitoh, K., Tatara, T., Iwamiya, K., Tamura, M., Tamura, K., Nakano, A., Tamura, U., Nakajima, T., Ichioka, G., Takeuchi, Y., Ayada, K., Torisu, R., Kamada, H., Matuoka, R., Turuoka, M., Sagara, Y., Nakamura, S., Sakasita, O., Mashimo, N., Sekiguchi, T., Kobayashi, S., Kishimoto, H., Takeuchi, T., Murakami, S., Koga, S., Ueno, M., Nishizawa, M., Nomoto, K., Kariya, A., Hayashi, M., Kobayashi, S., Mizuno, K., Mayama, S., Shinozuka, T., Maruyama, T., Ogiwara, T., Okui, K., Higurashi, K., Ito, T., Miyata, Y., Tamura, T., Ikeda, S., Nakata, J., Oshima, H., Mori, S., Otsuka, Y., Oki, I., Tasaka, S., Yamahatsu, J., Inaba, E., Sanada, K., Oura, T., Kinoshita, T., Akagi, M., Katsuhisa, F., Misumi, A., Urashima, K., Ninomiya, S., Hukami, M., Mori, T., Matsuo, Y., Seki, A., Kitamura, T., Mori, H., Yokota, R., Kawashima, S., Itoshima, T., Shimada, Y., Itoshima, T., Inoue, T., Fukuhara, J., Kubota, M., Ohta, W., Ohta, W., Kagaya, T., Abe, R., Kai, Y., Katono, S., Komatsu, K., Masuda, H., Inoue, S., Arakawa, H., Hamajima, T., Kitamura, T., Nakagawa, F., Tamura, H., Kiyonaga, G., Inui, H., Asai, H., Hayashi, N., Obata, H., Toki, F., Kakae, U., Yamauchi, D., Hisamitsu, T., Aziki, K., Tamiya, M., Watanabe, S., Kurokawa, K., Takemoto, T., Murakami, S., Kessoku, Y., Kuwana, H., Hino, K., Kato, A., Ito, A., Arakawa, Y., Ohono, Y., Hase, M., Ariga, K., Usui, R., Kutsukake, S., Nagamori, S., Nagano, H., Shimano, K., Ohya, T., Kikuchi, S., Ito, M., Hidano, S., Banno, H., Tomura, A., Kato, K., Koyama, T., Komatsu, T., Takei, T., Tomimura, K., Yamauchi, M., Sato, G., Sato, R., Haga, M., Toyokawa, S., Yamamoto, J., Ohtomi, S., Ishibashi, Y., Fukuda, M., Endo, R., Ueno, Y., Hisamitsu, T., Sasaki, T., Kobayashi, C., Kusakari, T., Yajima, T., Maeda, M., Kotoda, K., Okuda, K., Ariga, H., Takazawa, G., Nakamura, Y., Ohbayashi, A., Mitsui, H., Nakata, K., Suematsu, T., Kashiwagi, T., Hayashi, N., Baba, T., Tobimatsu, Y., Kamada, T., Abe, H., Matsuoka, K., Matsushima, S., Kamisaka, Y., Kitsuki, T., Ohnuki, H., Fujii, M., Inoue, R., Yamamoto, T., Wakisaka, G., Nakagawa, S., Nagata, K., Takebayashi, J., Nagashima, H., Tanaka, N., Kanai, K., Oda, T., Katayama, T., Furukawa, Y., Miyasaki, R., Noguchi, M., Hirose, K., Maezawa, H., Kano, H., Hirano, K., Ogino, M., Nishiwaki, K., Aoki, T., Morishita, T., Funatsu, K., Morita, A., Okazaki, I., Matsuzaki, S., Oda, M., Asakura, H., Kamegaya, K., Tsuchiya, M., Sambe, K., Kawakami, H., Kunimasa, T., Aimitsu, A., Yamashita, S., Miyoshi, A., Enzan, H., Ikehara, K., Shiozaki, Y., Sameshima, Y., Mizuno, T., Sasakawa, M., Nagi, S., Nagata, T., Fuwa, H., Tatsumi, K., Komatsu, K., Ozeki, T., Kaneda, M., Otsuki, M., Tadaki, H., Miura, K., Yamagata, S., Iwamura, K., Yamanaka, I., Sugimoto, E., Yamazaki, Y., Shiraishi, I., Yamanaka, T., Koike, H., Shimura, S., Hirayama, Y., Nishikawa, H., Kawamura, T., Kamiyama, Y., Takeda, H., Kamano, Y., Kitamura, O., Yamaoka, Y., Nanbu, H., Ozawa, K., Takasan, H., Honjo, I., Itakura, H., Akanuma, Y., Kagaya, T., Kaito, I., Sato, S., Sahara, H., Arisue, T., Kashimura, K., Motoyama, W., Hayashi, H., Okuyama, S., Ito, S., Inagaki, T., Kato, Y., Kakumu, S., Kurokawa, S., Yamawaki, T., Kusakabe, A., Hara, T., Funayama, A., Takahashi, T., Furuta, S., Omori, A., Hanaoka, S., Nagata, A., Tsukioka, J., Kiyosawa, K., Akahane, Y., Koike, Y., Oda, M., Tanaka, K., Kojima, M., Kawaguchi, Y., Kimura, A., Osamura, H., Kurihara, N., Okabe, K., Fujisawa, K., Takahashi, T., Kitami, N., Namihisa, T., Yamaguchi, K., Hisauchi, T., Nambu, M., Iijima, K., Rin, K., Kuroda, H., Kobayashi, N., Inami, Y., Shiga, K., Kon, T., Yamada, T., Yamada, T., Mizoguchi, Y., Enomoto, T., Monna, T., Yamamoto, S., Morisawa, S., Imoto, S., Uchita, K., Yamasawa, Y., Hiraide, S., Hikita, G., Takatsuki, K., Okimoto, Y., Nakagawa, J., Ito, K., Hirayama, C., Kawasaki, H., Irisa, T., Arimura, K., Amagase, H., Shibasaki, K., Tashiro, S., Ichida, F., Tozawa, T., Ishii, M., Inoue, E., Ikehara, H., Baba, S., Miyaji, Y., Nakajima, K., Shimizu, T., Shimizu, Y., Ohnishi, S., Sasaki, S., Kinami, Y., Mizukami, T., Nishida, Y., Nakagawa, T., Ojima, T., Takeshita, Y., Yamashita, T., Furuto, T., Ono, T., Yamaguchi, K., Mizuno, S., Tsumori, K., Miyagi, K., Suga, Y., Tatsumi, S., Kitano, A., Makiishi, H., Mitani, E., Mohri, S., Kamata, T., Kobayashi, K., Yamamoto, S., Yoshii, T., Takemoto, T., Suzuki, H., Hiratsuka, H., Takada, K., Maruyama, M., Takemoto, T., Suzuki, H., Katsu, K., Nomura, M., Kiyama, T., Hirabayashi, H., Yamashita, H., Masuyama, S., Takehara, Y., Sato, T., Abe, H., Sugiura, M., Shima, F., Ichihara, S., Yamasaki, Z., Fukuzawa, S., Horiguchi, Y., Takeda, T., Nakano, S., Kitamura, K., Miwa, M., Suzuke, T., Okada, K., Nakamura, T., Kikuchi, T., Mishima, K., Mandai, M., Kondo, H., Yamagata, Y., Uchida, Y., Harada, H., Nishizawa, M., Nomoto, K., Kariya, A., Ueno, M., Hayashi, M., Kobayashi, S., Mizuno, K., Shinozuka, T., Maruyama, T., Ogiwara, T., Okui, K., Miyake, N., Okada, M., Takahashi, K., Koizumi, H., Hayashi, T., Maeda, H., Abe, M., Takahashi, I., Matsumoto, M., Unoura, T., Iwasaki, A., Hattori, T., Tanaka, M., Hara, T., Sato, H., Hirashima, T., Shioda, A., Kawamura, I., Muto, M., Tsuchiya, R., Sato, Y., Ozawa, T., Hatano, T., Arae, H., Sekine, T., Tsukamoto, M., Shiratori, T., Asaki, S., Oba, E., Yamagata, H., Kobiyama, M., Hisamichi, S., Kitagawa, M., Kobayashi, N., Kurosawa, T., Tokimatsu, S., Kawasaki, S., Iwasa, A., Nagashima, K., Kodeki, K., Hoshizawa, T., Murakami, H., Yagi, T., Matsuda, T., Iwazaki, T., Suzuki, Y., Taketomi, H., Akaike, Y., Naramoto, J., Tsuru, T., Inoue, M., Nagase, T., Kato, K., and Kohyama, K.
- Published
- 1973
- Full Text
- View/download PDF
3. Study on Safety and Efficiency of Laparoscopic Adhesiotomy Using SURGIWAND™ and the Uterine Manipulator for Ovarian and Pelvic Endometriosis Patients with Cul de Sac Obliteration
- Author
-
Kusakari, T., primary, Ueta, M., additional, Mori, K., additional, and Tatsumi, N., additional
- Published
- 2008
- Full Text
- View/download PDF
4. P15.12: Laminaria (L) dilatation and curettage in Cesarean scar pregnancy (CSP) with a literature review
- Author
-
Hoshino, T., primary, Okada, Y., additional, Takaoka, A., additional, Yamada, S., additional, Kusakari, T., additional, Nakamura, M., additional, Kojima, K., additional, Ihara, Y., additional, and Kita, M., additional
- Published
- 2006
- Full Text
- View/download PDF
5. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro
- Author
-
Kusakari, T, primary, Kariya, M, additional, Mandai, M, additional, Tsuruta, Y, additional, Hamid, A A, additional, Fukuhara, K, additional, Nanbu, K, additional, Takakura, K, additional, and Fujii, S, additional
- Published
- 2003
- Full Text
- View/download PDF
6. Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibility
- Author
-
Yoshida, H, primary, Ito, K, additional, Kusakari, T, additional, Ida, K, additional, Ihara, Y, additional, Mori, T, additional, and Matsumura, M, additional
- Published
- 1994
- Full Text
- View/download PDF
7. Influence of experimental hepatic disorder on plasma cholesterol esters (I)
- Author
-
Miwa, S., Okazaki, N., Kotoda, K., and Kusakari, T.
- Published
- 1967
- Full Text
- View/download PDF
8. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature
- Author
-
Mandai, M., Konishi, I., Tsuruta, Y., Suginami, N., Kusakari, T., Iwasaki, T., and Fujii, S.
- Published
- 2001
- Full Text
- View/download PDF
9. Intracellular Transfer of Nucleic Acids
- Author
-
Kusakari T, Yano M, and Mura Y
- Subjects
Biochemistry ,Chemistry ,medicine.drug_class ,Ascites ,Antibiotics ,medicine ,General Medicine ,medicine.symptom ,Molecular Biology ,Intracellular - Published
- 1963
- Full Text
- View/download PDF
10. Competitive Antagonism Between Isoproterenol and a New Beta-Receptor Adrenergic Blocking Agent, Propranolol.
- Author
-
Nakano, J., primary and Kusakari, T., additional
- Published
- 1965
- Full Text
- View/download PDF
11. Kanzo
- Author
-
Maeda, M., primary, Sasaki, T., additional, Kobayashi, C., additional, Musha, H., additional, Mori, H., additional, Hisamitsu, T., additional, Fukuyama, Y., additional, Kusakari, T., additional, Kanda, Y., additional, Yajima, T., additional, Kotoda, K., additional, and Okuda, K., additional
- Published
- 1973
- Full Text
- View/download PDF
12. Effect of Propranolol on the Peripheral Circulation.
- Author
-
Nakano, J., primary and Kusakari, T., additional
- Published
- 1965
- Full Text
- View/download PDF
13. Effect of Propranolol on the Peripheral Vascular Bed
- Author
-
NAKANO, J., primary and KUSAKARI, T., additional
- Published
- 1966
- Full Text
- View/download PDF
14. Effect of beta adrenergic blockade on the cardiovascular dynamics
- Author
-
Nakano, J, primary and Kusakari, T, additional
- Published
- 1966
- Full Text
- View/download PDF
15. EFFECTS OF SYNTHETIC ELEDOISIN ON PLASMA FREE FATTY ACID AND BLOOD GLUCOSE LEVELS IN DOGS
- Author
-
KUSAKARI, T., primary and NAKANO, J., additional
- Published
- 1966
- Full Text
- View/download PDF
16. Effects of Synthetic Angiotensin on Plasma Free Fatty Acid and Blood Glucose-levels
- Author
-
NAKANO, J., primary and KUSAKARI, T., additional
- Published
- 1966
- Full Text
- View/download PDF
17. Rice Bran Supplement Containing A Functional Substance, the Novel Peptide Leu-Arg-Ala, has Anti-Hypertensive Effects: A Double-Blind, Randomized, Placebo-Controlled Study.
- Author
-
Ogawa Y, Shobako N, Fukuhara I, Satoh H, Kobayashi E, Kusakari T, Suwa M, Matsumoto M, and Ishikado A
- Subjects
- Double-Blind Method, Female, Heart Rate drug effects, Humans, Male, Middle Aged, Peptides chemistry, Plant Proteins chemistry, Blood Pressure drug effects, Dietary Supplements, Hypertension drug therapy, Oryza chemistry, Peptides pharmacology, Plant Proteins pharmacology
- Abstract
The anti-hypertensive effect of processed rice bran (PRB) was recently reported, for which the novel peptide Leu-Arg-Ala (LRA) was identified as the functional substance. The purpose of this study was to assess the anti-hypertensive effects of a rice bran supplement containing PRB in individuals with high-normal blood pressure (systolic blood pressure (SBP): 130⁻139 mmHg and/or diastolic blood pressure (DBP): 85⁻89 mmHg) or grade 1 hypertension (SBP: 140⁻159 mmHg and/or DBP: 90⁻99 mmHg). One hundred individuals with high-normal blood pressure or grade 1 hypertension were recruited to participate in this double-blind, randomized, placebo-controlled study. Participants were randomly allocated to the placebo group ( n = 50) or the test group (n = 50). Each group took four test tablets (43 μg LRA/day) or four placebo tablets daily. The decrease in blood pressure in the test group compared with the placebo group was the primary outcome. Adverse events were recorded and hematological/urinary parameters measured to determine the safety of the supplement, which was the secondary outcome. In total, 87 participants completed the study. The SBP of the test group at 12 weeks was significantly lower than that of the placebo group (p = 0.0497). No serious adverse events were observed. Daily consumption of a rice bran supplement containing PRB can safely improve mildly elevated blood pressure., Competing Interests: Y.O., N.S., E.K., T.K., M.S., M.M., and A.I. are employed by Sunstar Inc. I.F. declare no conflicts of interest. H.S. is employed by New Drug Research Center Inc. Test tablets were prepared by Sunstar Inc.
- Published
- 2019
- Full Text
- View/download PDF
18. Vasorelaxant and Antihypertensive Effects That Are Dependent on the Endothelial NO System Exhibited by Rice Bran-Derived Tripeptide.
- Author
-
Shobako N, Ishikado A, Ogawa Y, Sono Y, Kusakari T, Suwa M, Matsumoto M, and Ohinata K
- Subjects
- Animals, Antihypertensive Agents isolation & purification, Human Umbilical Vein Endothelial Cells metabolism, Humans, Hypertension metabolism, Hypertension physiopathology, Male, Oligopeptides isolation & purification, Plant Extracts isolation & purification, Rats, Rats, Inbred SHR, Seeds chemistry, Vasodilation drug effects, Vasodilator Agents isolation & purification, Antihypertensive Agents administration & dosage, Human Umbilical Vein Endothelial Cells drug effects, Hypertension drug therapy, Nitric Oxide metabolism, Oligopeptides administration & dosage, Oryza chemistry, Plant Extracts administration & dosage, Vasodilator Agents administration & dosage
- Abstract
We recently identified a novel, potent antihypertensive peptide, Leu-Arg-Ala (LRA; minimum effective dose = 0.25 mg/kg), from rice bran protein. In this study, we found that LRA potently relaxed mesenteric arteries isolated from spontaneously hypertensive rats (SHRs) (EC
50 = 0.1 μM). In contrast, the vasorelaxant activity of each amino acid that constitutes the LRA tripeptide was remarkably attenuated. The LRA-induced vasorelaxant activity was inhibited by N(G)-nitro-l-arginine methyl ester (L-NAME; NO synthase [NOS] inhibitor) but not by an antagonist of bradykinin B2 and Mas receptors or by a phosphoinositide 3-kinase inhibitor. The antihypertensive effect induced after the oral administration of LRA was inhibited by L-NAME. LRA also induced the phosphorylation of endothelial NOS in human umbilical vein endothelial cells. Taken together, LRA may exhibit antihypertensive effects via NO-mediated vasorelaxation. LRA is the first example of a NO-dependent vasorelaxant peptide identified from rice bran protein.- Published
- 2019
- Full Text
- View/download PDF
19. A Novel Antihypertensive Peptide Identified in Thermolysin-Digested Rice Bran.
- Author
-
Shobako N, Ogawa Y, Ishikado A, Harada K, Kobayashi E, Suido H, Kusakari T, Maeda M, Suwa M, Matsumoto M, Kanamoto R, and Ohinata K
- Subjects
- Angiotensin-Converting Enzyme Inhibitors pharmacology, Animals, Antihypertensive Agents pharmacology, Male, Peptides pharmacology, Rats, Rats, Inbred SHR, Angiotensin-Converting Enzyme Inhibitors isolation & purification, Antihypertensive Agents isolation & purification, Oryza chemistry, Peptides isolation & purification, Thermolysin metabolism
- Abstract
Scope: Hypertension is a risk factor for arteriosclerosis. In this study, we investigate the antihypertensive effect of protease-digested rice bran in a spontaneously hypertension rat (SHR) model. We also purify a novel antihypertensive peptide from the digest., Methods and Results: Thermolysin-digested rice bran (TRB) is administered to SHRs for 4 weeks, and systolic blood pressure (SBP) was measured weekly using the tail-cuff method. TRB shows an antihypertensive effect in a dose-dependent manner. TRB also reduces angiotensin I-converting enzyme (ACE) activity in lung tissue and serum troponin I levels. TRB is fractionated by HPLC and ACE-inhibitory activity in the HPLC fractions is measured. Peptides LRA and YY are identified from the two fractions with the strongest ACE-inhibitory activity. Amino acid sequence of these peptides are found in a vicilin-like seed storage protein, and identified in rice bran protein using the peptide mass fingerprint method. We confirm that LRA and YY are cleaved by thermolysin digestion of a model synthetic peptide. Orally administered LRA (0.25 mg kg
-1 ) or YY (0.5 mg kg-1 ) lowers the SBP of SHRs at 4 h after administration., Conclusion: We identify a novel, orally active antihypertensive peptide, LRA from the digest of rice bran protein., (© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2018
- Full Text
- View/download PDF
20. Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity.
- Author
-
Baba T, Mori S, Matsumura N, Kariya M, Murphy SK, Kondoh E, Kusakari T, Kuroda H, Mandai M, Higuchi T, Takakura K, Fukuda MN, and Fujii S
- Subjects
- Antineoplastic Agents therapeutic use, Cisplatin therapeutic use, Drug Resistance, Neoplasm, Female, Humans, Ovarian Neoplasms drug therapy, Prognosis, Reproducibility of Results, Risk Factors, Sensitivity and Specificity, Biomarkers, Tumor analysis, Cell Adhesion Molecules analysis, Neoplasm Proteins analysis, Ovarian Neoplasms diagnosis, Ovarian Neoplasms metabolism, Risk Assessment methods
- Abstract
Ovarian cancer is the leading cause of death in women with gynecological malignancies, with prognosis of advanced stage tumors determined by chemotherapeutic response and the success of tumor resection. Since aberrant RAS pathway activation is frequent in ovarian cancer, study of in vitro RAS-induced transformation and accompanying genomic expression changes in ovarian surface epithelial cells is imperative for development of new therapeutic modalities and for understanding tumorigenesis. cDNA microarray analysis revealed TROPHONIN (TRO), a homophilic adhesion molecule involved in blastocyst implantation, was among the genes most downregulated by RAS induction. TRO expression is higher in cisplatin-sensitive cancer cell lines and positively correlates with prognoses in ovarian cancers. TRO knockdown by RNA interference conferred cisplatin resistance and led to increased invasiveness of cultured ovarian cancer cells. These findings underscore the importance of TRO in tumorigenesis, and suggest that TRO may be a useful biomarker for cisplatin sensitivity and invasive potential.
- Published
- 2007
- Full Text
- View/download PDF
21. Selective oxidation of benzene to phenol with molecular oxygen on rhenium/zeolite catalysts.
- Author
-
Kusakari T, Sasaki T, and Iwasawa Y
- Abstract
Zeolite-supported rhenium catalysts are active for selective oxidation of benzene with molecular oxygen, where coexisting ammonia is prerequisite to the direct phenol synthesis.
- Published
- 2004
- Full Text
- View/download PDF
22. PEP-19 overexpression in human uterine leiomyoma.
- Author
-
Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Kusakari T, Momma C, Shime H, Yagi H, Konishi M, Suzuki A, Matsumura N, Nanbu K, Fujita J, and Fujii S
- Subjects
- Adult, Blotting, Northern, Cell Line, Tumor, Female, Humans, Immunohistochemistry, Leiomyoma genetics, Leiomyoma pathology, Microscopy, Confocal, Middle Aged, Myometrium pathology, Nerve Tissue Proteins genetics, Oligonucleotide Array Sequence Analysis, RNA, Messenger metabolism, Up-Regulation, Uterine Neoplasms genetics, Uterine Neoplasms pathology, Leiomyoma metabolism, Nerve Tissue Proteins metabolism, Uterine Neoplasms metabolism
- Abstract
Although uterine leiomyomas represent one of the most common neoplasms in adult women, their pathogenesis remains poorly understood. A cDNA microarray analysis was performed to search for candidate genes expressed to a greater degree in leiomyoma compared with matched myometrium. A total of 15 candidate genes was obtained; neuron-specific protein PEP-19 (Purkinje cell protein 4; PCP 4) exhibited a striking difference in expression between leiomyoma and myometrium. Although PEP-19 expression has been reported exclusively in the central nervous system, the present study demonstrated that PEP-19 is also expressed in other human organs, including prostate, kidney and uterus. To clarify the role of PEP-19 in the pathogenesis of leiomyomas, PEP-19 expression was investigated for a series of human leiomyoma, as well as normal myometrium and leiomyosarcoma. PEP-19 mRNA and protein expression were much stronger in leiomyomas compared with normal myometrium, suggesting that PEP-19 might be involved in leiomyoma pathogenesis.
- Published
- 2003
- Full Text
- View/download PDF
23. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
- Author
-
Hamid AA, Mandai M, Fujita J, Nanbu K, Kariya M, Kusakari T, Fukuhara K, and Fujii S
- Subjects
- Adult, Aged, Blotting, Western, Endometrial Neoplasms pathology, Female, Humans, Immunohistochemistry, Ki-67 Antigen analysis, Middle Aged, Neoplasm Staging, Endometrial Hyperplasia metabolism, Endometrial Neoplasms chemistry, Endometrium chemistry, RNA-Binding Proteins analysis
- Abstract
Cold-inducible RNA-binding protein (CIRP), an 18-kD protein in the mouse and human, is induced by lowering the temperature of cultured cells. CIRP is possibly a cell cycle regulator because its overexpression results in prolongation of G1 phase in vitro. We investigated the immunohistochemical expression of CIRP in 39 endometrial carcinomas, 12 endometrial hyperplasias, and 27 normal endometria using polyclonal antibody against CIRP and confirmed by Western blot analysis. CIRP was localized in the nuclei of glandular, stromal, and endothelial cells. The intensity of CIRP expression in glandular cells during the menstrual cycle was inversely proportional to its proliferative (Ki-67) activity, whereas it remained unchanged in stromal and vascular endothelial cells. The intensity of CIRP expression in hyperplastic glands was variable, whereas CIRP expression was absent or markedly reduced in most of the endometrial carcinomas. These results suggest that CIRP may participate in the cell cycle regulation of normal endometrium and the loss of its expression may be involved in endometrial carcinogenesis.
- Published
- 2003
- Full Text
- View/download PDF
24. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.
- Author
-
Yura Y, Mandai M, Konishi I, Hamid AA, Tsuruta Y, Kusakari T, and Fujii S
- Subjects
- Endometrial Neoplasms genetics, Endometrial Neoplasms pathology, Female, Humans, Immunohistochemistry, Middle Aged, Neoplasm Proteins genetics, Neoplasm Staging, RNA, Messenger biosynthesis, RNA, Messenger genetics, Receptors, Estrogen biosynthesis, Receptors, Estrogen genetics, Receptors, Progesterone biosynthesis, Receptors, Progesterone genetics, Reverse Transcriptase Polymerase Chain Reaction, Tumor Suppressor Protein p53 biosynthesis, Tumor Suppressor Protein p53 genetics, Acid Anhydride Hydrolases, Endometrial Neoplasms metabolism, Neoplasm Proteins biosynthesis
- Abstract
Background: The fragile histidine triad (FHIT) gene is a candidate tumor suppressor gene located at 3p14.2, and the absence or reduction of Fhit protein expression has recently been reported in various carcinomas., Materials and Methods: We examined the expression of Fhit protein in 50 endometrial carcinomas and 19 normal endometrial tissues by immunohistochemistry, and this expression was correlated with clinicopathological parameters, p53 expression, sex steroid receptor status and abnormal FHIT transcripts., Results: All the specimens of normal endometrial gland in the proliferative phase exhibited relatively strong Fhit expression, while most of endometrial tissues in the secretory phase showed weak Fhit expression. In 50 endometrial carcinomas, immunoreactivity for Fhit protein was strong in 21 cases (42%), weak in 22 cases (44%) and partially or totally absent in the remaining 7 cases (14%). There were significant correlations of negative Fhit expression with high tumor grade (p = 0.033) and with advanced stage (p = 0.048). On the other hand, abnormal FHIT transcripts lacking several exons were found in 29% of cases. Neither p53 nor sex steroid receptor status were significantly related with the loss of Fhit expression., Conclusion: The loss of Fhit protein expression may be associated with aggressive phenotype of endometrial carcinomas.
- Published
- 2003
25. Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53.
- Author
-
Shime H, Kariya M, Orii A, Momma C, Kanamori T, Fukuhara K, Kusakari T, Tsuruta Y, Takakura K, Nikaido T, and Fujii S
- Subjects
- Blotting, Western, Cell Cycle drug effects, Cell Division drug effects, Cell Division physiology, Cyclin-Dependent Kinase 2, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinases antagonists & inhibitors, Cyclins genetics, Female, G1 Phase, Genes, p53, Humans, Muscle, Smooth cytology, Myometrium cytology, Protein Serine-Threonine Kinases antagonists & inhibitors, Tumor Cells, Cultured, CDC2-CDC28 Kinases, Gene Expression Regulation physiology, Leiomyoma pathology, Uterine Neoplasms pathology, ortho-Aminobenzoates pharmacology
- Abstract
Uterine leiomyoma is a mesenchymal tumor composed of smooth muscle cells with fibrous tissues and many mast cells. Tranilast is known to suppress fibrosis or to work as a mast cell stabilizer and is reported to inhibit proliferation of vascular smooth muscle cells. In this study, we examined the effects of tranilast on cultured human leiomyoma cells in vitro to evaluate whether this agent has the potential to inhibit the growth of uterine leiomyomas. Tranilast inhibited the proliferation of cultured leiomyoma cells in a dose-dependent manner without any cytotoxic effect or induction of apoptosis. In association with the inhibitory effect, tranilast induced the cyclin-dependent kinase (CDK) inhibitor p21(waf1) and tumor suppressor gene p53 and decreased CDK2 activity. These results suggest that tranilast arrests the proliferation of uterine leiomyoma cells at the G0/G1 phase, through the suppression of CDK2 activity via an induction of p21(waf1) and p53. Tranilast was concluded to be a potent agent to inhibit proliferative activity of uterine leiomyoma cells.
- Published
- 2002
- Full Text
- View/download PDF
26. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
- Author
-
Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, and Fujii S
- Subjects
- Adult, Aged, Antibodies, Monoclonal, Cell Division, Cell Transformation, Neoplastic, Endometrial Neoplasms pathology, Female, Humans, Hyperplasia, Immunohistochemistry, Middle Aged, MutS Homolog 2 Protein, Proliferating Cell Nuclear Antigen biosynthesis, DNA Repair, DNA-Binding Proteins, Endometrial Neoplasms genetics, Endometrium pathology, Gene Expression Regulation, Neoplastic, Menstrual Cycle physiology, Proto-Oncogene Proteins biosynthesis
- Abstract
Background: The role of hMSH2 protein, one of the major DNA repair proteins, until now, had not been elucidated in terms of normal endometrial function during the menstrual cycle. The current study was designed to address this issue and to determine whether the expression of hMSH2 is altered in the course of endometrial carcinogenesis., Methods: Immunohistochemical reactivity with a monoclonal antibody against the hMSH2 protein was examined in endometrial tissue specimens from 45 patients with normal endometrium, 51 patients with endometrial hyperplasia, and 27 patients with endometrial carcinoma. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) also was studied in the same samples as a measure of the proliferative activity and was compared with hMSH2 expression in each sample., Results: The functional layer of normal endometrium displayed cyclic changes in hMSH2 protein expression during the menstrual cycle, showing positive expression in the proliferative phase and becoming weak to negative in the secretory phase. This expression pattern was similar to that of PCNA. Sixty-three percent of endometrial carcinomas showed strong positivity for both hMSH2 and PCNA expression, and 7.4% had an intensity of hMSH2 protein expression similar to that found in normal proliferative endometrial glandular cells. There was only 1 sample (3.7%) that was completely negative for hMSH2 expression, and 26% of samples were weakly positive for PCNA and hMSH2 protein. All simple hyperplasias and the majority of complex and atypical hyperplasias showed positive immunoreactivity for hMSH2 and PCNA., Conclusions: This study demonstrates that hMSH2 protein expression changes during the menstrual cycle in parallel with proliferative activity. In most patients with sporadic endometrial carcinoma, the expression of hMSH2 protein is consistent with PCNA expression. In contrast, loss of hMSH2 expression is observed rarely in patients with sporadic endometrial carcinoma., (Copyright 2002 American Cancer Society. DOI 10.1002/cncr.10341)
- Published
- 2002
27. Visual deprivation stimulates the exchange of the fibrous sclera into the cartilaginous sclera in chicks.
- Author
-
Kusakari T, Sato T, and Tokoro T
- Subjects
- Animals, Chickens, Collagen ultrastructure, Decorin, Extracellular Matrix Proteins, Fibrosis, Insulin-Like Growth Factor II metabolism, Microscopy, Electron, Microscopy, Electron, Scanning, Myopia metabolism, Myopia physiopathology, Proteoglycans metabolism, Sclera growth & development, Sclera metabolism, Sensory Deprivation, Transforming Growth Factor alpha metabolism, Transforming Growth Factor beta metabolism, Myopia pathology, Sclera ultrastructure
- Abstract
Form deprivation myopia in chicks is a widely accepted model to study visually-regulated postnatal ocular growth. The chick sclera has a cartilaginous layer as well as the fibrous layer found in mammals. It appears that a dynamic relationship exists between these two layers during visual deprivation-induced growth. The changes in the fibrous sclera of myopic eyes, however, have not been previously described. This investigation is focused on the comparative morphological analyses of the cartilaginous and fibrous scleral changes in myopic chick eyes. The fibrous scleral changes in the posterior segment of myopic eyes were examined in detail using light and electron microscopy, and the expression of growth factors was analysed by immunohistochemistry. In the posterior segment of myopic eyes the border between the cartilaginous and fibrous layers was indistinct because of collagen bundles of the fibrous sclera that spread into the cartilaginous sclera, whereas in control eyes the distinction was clear. Various types of transitional cells, from fibroblast-like mesenchymal cells to chondrocytes, were found in the border between the cartilaginous and fibrous layers. Collagen fibrillar diameters of the fibrous sclera in the posterior segment of myopic eyes were smaller than in control, whereas those in the equatorial segment were almost the same in myopic and control eyes although the distribution of sizes was obviously different. Thus, changes in the fibrous sclera in myopic eyes of chicks seem to be similar to scleral changes in myopic eyes of mammals. The cells in the posterior sclera of myopic eyes were more intensely immunostained for TGF-beta and IGF-II than control, whereas no immunoreaction of TGF-alpha could be detected in either control or myopic eyes. These results suggest that the structural characteristics of the posterior sclera are different from those of the anterior and equatorial segments. Undifferentiated mesenchymal cells might be concentrically distributed exclusively in the innermost layer of posterior fibrous sclera. TGF-beta and IGF-II might influence cell growth, differentiation, and migration in the exaggerated scleral growth accompanying myopia., (Copyright 2001 Academic Press.)
- Published
- 2001
- Full Text
- View/download PDF
28. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature.
- Author
-
Mandai M, Konishi I, Tsuruta Y, Suginami N, Kusakari T, Iwasaki T, and Fujii S
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Chromogranin A, Chromogranins analysis, Cisplatin therapeutic use, Fallopian Tubes surgery, Fatal Outcome, Female, Humans, Hysterectomy, Immunohistochemistry, Intestinal Obstruction etiology, Krukenberg Tumor pathology, Krukenberg Tumor therapy, Ovarian Neoplasms pathology, Ovarian Neoplasms therapy, Ovariectomy, Peritonitis etiology, Appendiceal Neoplasms pathology, Carcinoid Tumor pathology, Krukenberg Tumor secondary, Ovarian Neoplasms secondary
- Abstract
Appendiceal neoplasms with ovarian metastasis are rare. A 35-year-old woman with a left ovarian tumor underwent left salpingo-oophorectomy, partial resection of the right ovary, and a total hysterectomy. Pathological diagnosis of both ovaries was typical, Krukenberg tumor with signet-ring cells, and the second laparotomy revealed an occult appendiceal tumor to be the primary lesion. The appendix showed no evidence of malignant change of the mucosa, but the tumor cells were observed infiltrating from the basiglandular region into the underlying stroma, associated with mucocele. Although, argentaffin and argyrophil staining were negative, a few tumor cells showed immunohistochemical positivity for Chromogranin A. Accordingly, the tumor was diagnosed as adenocarcinoid rather than adenocarcinoma of the appendix. A review of the literature showed less than 40 cases of metastatic ovarian tumor from appendiceal primary, one-third of which were occult and could be detected at the second laparotomy. Cisplatin-based chemotherapy may have partial effect in the treatment of patient with adenocarcinoid tumor.
- Published
- 2001
- Full Text
- View/download PDF
29. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1.
- Author
-
Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, and Fujii S
- Subjects
- Apoptosis genetics, Cell Line, DNA Fragmentation, Epithelial Cells drug effects, Epithelial Cells metabolism, Female, Humans, Insulin-Like Growth Factor I pharmacology, Iodine Radioisotopes metabolism, Ovary drug effects, Receptors, LH genetics, Apoptosis physiology, Chorionic Gonadotropin pharmacology, Insulin-Like Growth Factor I metabolism, Ovary metabolism, Receptors, LH metabolism
- Abstract
Gonadotropins including luteinizing hormone (LH) or human chorionic gonadotropin (hCG) have been implicated as playing an important role in the development of epithelial ovarian carcinomas, most of which are believed to originate from the ovarian surface epithelium (OSE). To address this issue, we examined the expression of LH/hCG receptors and the influence of hCG on cell proliferation and on the apoptosis of cultured human OSE cells. RT-PCR and binding assay revealed that OSE cells express the LH/hCG receptor mRNA and have specific binding activity for hCG. Treatment with hCG stimulated the proliferation of OSE cells in a dose-dependent manner. In addition, hCG treatment inhibited the apoptosis of OSE cells induced by serum deprivation. Among the apoptosis-related genes, hCG treatment did not change the mRNA levels of bcl-2, bax and IGF-1 receptor but significantly increased that of IGF-1. Treatment with IGF-1 alone also suppressed the apoptosis of OSE cells, and treatment by hCG along with neutralization antibody against IGF-1 receptor reversed the anti-apoptotic effect of hCG. Accordingly, LH/hCG signaling followed by up-regulation of IGF-1 is involved in the inhibition of apoptosis of OSE cells, the possible histogenetic origin of epithelial ovarian carcinomas.
- Published
- 2001
- Full Text
- View/download PDF
30. Preferential changes in hepatosplanchnic hemodynamics in patients with borderline hypertension.
- Author
-
Sugawara T, Noshiro T, Kusakari T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W, and Miura Y
- Subjects
- Adolescent, Adult, Area Under Curve, Cardiac Output physiology, Female, Humans, Male, Middle Aged, Regional Blood Flow physiology, Renal Circulation physiology, Vascular Resistance physiology, Hemodynamics physiology, Hypertension physiopathology, Liver Circulation physiology, Splanchnic Circulation physiology
- Abstract
To investigate changes in systemic and regional hemodynamics during the development of human hypertension, we simultaneously measured cardiac index (CI) by the indocyanine green (ICG) dye dilution method, hepatosplanchnic blood flow (HBF) by the ICG clearance method using a two-compartment model, and renal blood flow (RBF) by the p-aminohippurate clearance method in patients with borderline and essential hypertension. In patients with borderline hypertension (BH, n = 27), HBF (435 +/- 15 ml/min/m2) and HBF/CI (16 +/- 1%) were significantly (p < 0.05) lower than in age-matched normotensive controls (528 +/- 21 and 19 +/- 1, respectively, n = 21), while CI, RBF and RBF/CI were similar. In patients with essential hypertension (EH, n = 32), HBF, RBF, and RBF/CI were all significantly (p < 0.01) lower than in the control subjects. Hepatosplanchnic vascular resistance (HVR) in patients with BH was preferentially increased, while total peripheral resistance (TPR) and renal vascular resistance (RVR) remained in the normal range. In patients with EH, TPR, HVR, and RVR were all increased. These results indicate that hemodynamic changes in patients with BH do not occur uniformly among the various regional circulations and suggest that hemodynamic changes in the hepatosplanchnic region precede those in other organ circulations during the development of human hypertension.
- Published
- 1997
- Full Text
- View/download PDF
31. Regional scleral changes in form-deprivation myopia in chicks.
- Author
-
Kusakari T, Sato T, and Tokoro T
- Subjects
- Animals, Animals, Newborn, Biomarkers, Chickens, Eye pathology, Immunohistochemistry, Male, Microscopy, Electron, Myopia etiology, Proliferating Cell Nuclear Antigen metabolism, Sclera anatomy & histology, Sclera metabolism, Sclera ultrastructure, Myopia pathology, Sclera pathology
- Abstract
Similar neurochemical events appear to be involved in the development of myopia in chicks and mammals. The rapid post-hatching development of the chick is ideal for studying experimental myopia. In this investigation, one eye of 2-day-old chicks was deprived of form vision for 2 weeks and then compared to the fellow, non-deprived eye by immunohistochemistry and light and electron microscopy. All deprived eyes showed a high refractive error and ocular enlargement. In deprived eyes, the posterior cartilaginous sclera was thicker and the fibrous sclera of the same section was thinner than the control. Scleral morphological changes were restricted to a central button 6-7 mm in diameter (the posterior pole) within the posterior hemisphere, further divided into posterotemporal and posteronasal parts. The most enlarged, posterior cartilaginous structure of deprived sclera could be divided into an inner and an outer zone. The inner zone had many unevenly-arranged chondrocytes, each having a well-developed granular endoplasmic reticulum and Golgi complex and a very irregular cell surface. Numerous S-phase cells and isogenous groups were detected in the outer zone. Hypertrophic chondrocytes were often observed in the innermost region of the outer zone and the outermost region of the inner zone. The boundary between the outer fibrous sclera and the cartilaginous sclera was irregular and obscured in myopic eyes. Spindle-shaped chondrocytes were seen to be in contact with each other. Thick collagen fibrils, usually seen only in the outer fibrous sclera, were present among the chondrocytes. Results of this morphological study suggest an increased proliferation of chondrocytes and active synthesis of extracellular matrix in visually deprived eyes. The elongation of the ocular axis that accompanies myopia is caused primarily by an active remodeling and differentiation in a restricted section of the posterior scleral cartilage. These facts indicate the posterior scleral cartilage may be more immature than cartilage in anterior and lateral segments.
- Published
- 1997
- Full Text
- View/download PDF
32. Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy.
- Author
-
Noshiro T, Honma H, Shimizu K, Kusakari T, Watanabe T, Akama H, Shibukawa S, Miura W, Abe K, and Miura Y
- Subjects
- Adrenal Gland Neoplasms therapy, Adult, Chemotherapy, Adjuvant, Cyclophosphamide administration & dosage, Dacarbazine administration & dosage, Follow-Up Studies, Humans, Lung diagnostic imaging, Male, Norepinephrine blood, Norepinephrine metabolism, Pheochromocytoma therapy, Radiography, Abdominal, Radiotherapy, Adjuvant, Time Factors, Tomography, X-Ray Computed, Vincristine administration & dosage, Adrenal Gland Neoplasms drug therapy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Pheochromocytoma drug therapy
- Abstract
Two patients with malignant pheochromocytoma were treated with a combination chemotherapy regimen consisting of cyclophosphamide vincristine, and dacarbazine (CVD). With the first few cycles of the treatment, one patient, a 29-year-old man had a marked improvement of clinical symptoms and decreases in tumor size and catecholamine levels in plasma and urine. He had been in a clinically stable condition for 18 months but died 34 months after starting of this treatment because the CVD regimen became ineffective and rapid growth of the metastatic tumors occurred. The other patient, a 35-year-old man showed no significant change in tumor size but decreases in hormonal levels in response to CVD regimen. The patient has been in clinically stable condition in a follow-up of 24 months. The combined chemotherapy with CVD appears to be effective for advanced malignant pheochromocytoma.
- Published
- 1996
- Full Text
- View/download PDF
33. Expression of class II MHC molecules in the rat pineal gland during development and effects of treatment with carbon tetrachloride.
- Author
-
Sato T, Kaneko M, Hama A, Kusakari T, and Fujieda H
- Subjects
- Animals, Antibodies, Monoclonal, Immunoblotting, Immunoenzyme Techniques, Immunohistochemistry, Male, Pineal Gland growth & development, Proliferating Cell Nuclear Antigen analysis, Rats, Rats, Wistar, Staining and Labeling, Carbon Tetrachloride pharmacology, Histocompatibility Antigens Class II physiology, Pineal Gland drug effects, Pineal Gland immunology
- Abstract
Cells expressing major histocompatibility complex (MHC) class II (Ia) antigen have been examined during the development of rat pineals and in the pineal gland of adult rats treated with carbon tetrachloride. Cells positive for MHC class II are first detected in the pineal gland of the 7-day-old rat. These positive cells increase in number gradually during development, MHC class II immunoreactivity reaching adult levels at 4 weeks after birth. The MHC class II antigen is intensely labeled on the cell surface, and labeled cells are distributed throughout the organ, several positive cells being gathered into groups. The positive cells are small (7-12 microm in diameter), irregular in shape, and frequently exhibit one or more processes. At the electron-microscopic level, the cytoplasm of positive cells contains few organelles, variously sized empty vacuoles, and a few electron-dense lysosome-like structures. Pinealocytes with synaptic ribbons have been found adjacent to immunoreactive cells. Double-immunoperoxidase staining for MRC OX6, MRC OX42, and ED1 results in OX6(-)/ED1(+)/OX42(+), OX6(-)/ED1(-)/OX42(+), and OX6(+)/ED1(-)/OX42(- )cells. These findings suggest that OX6-positive cells in the pineal can be considered as peripheral dendritic cells. The number of cells expressing MHC class II (Ia) antigen significantly increases in the pineal gland of rats after treatment with carbon tetrachloride (P<0.005). Our results indicate that at least some of the OX6-positive cells migrate into the gland from the circulation under these conditions.
- Published
- 1996
- Full Text
- View/download PDF
34. Two cases of pheochromocytoma diagnosed histopathologically as mixed neuroendocrine-neural tumor.
- Author
-
Watanabe T, Noshiro T, Kusakari T, Akama H, Shibukawa S, Miura W, Abe K, Kimura N, and Miura Y
- Subjects
- Adrenal Gland Neoplasms etiology, Adult, Humans, Male, Pheochromocytoma etiology, Adrenal Gland Neoplasms pathology, Mixed Tumor, Malignant pathology, Neuroblastoma pathology, Pheochromocytoma pathology
- Abstract
We treated two rare cases of pheochromocytoma which were histopathologically diagnosed as mixed neuroendocrine-neural tumor (MNNT): a 35-year-old male patient associated with ganglioneuroblastoma and cutaneous neurofibromatosis and a 42-year-old male patient with ganglioneuroma. Both patients showed typical clinical manifestations of pheochromocytoma without any familial traits. Although each of the diseases has its own entity and clinical features, these tumors are all derived from the neural crest tissues. The tumorigenesis of MNNT is still unknown. Here, a brief review of the recent literature on this subject is discussed.
- Published
- 1995
- Full Text
- View/download PDF
35. Renal dopamine spillover rate using 3H-dopamine radiotracer technique as an index of renal dopaminergic nerve activity.
- Author
-
Noshiro T, Akama H, Watanabe T, Kusakari T, Honma H, Shibukawa S, Miura W, Abe K, and Miura Y
- Subjects
- Animals, Blood Pressure physiology, Dopamine blood, Heart Rate physiology, Kidney innervation, Kinetics, Male, Norepinephrine blood, Norepinephrine metabolism, Norepinephrine physiology, Rabbits, Renal Circulation physiology, Sympathetic Nervous System physiology, p-Aminohippuric Acid metabolism, Dopamine metabolism, Kidney metabolism
- Abstract
Renal and total dopamine (DA) spillover rates at rest were measured in 25 conscious rabbits with chronically implanted renal vein catheters. Renal DA spillover rate was calculated from veno-arterial difference in plasma free DA concentrations across the kidney corrected by the fractional extraction of infused 3H-DA. Plasma free DA concentrations were 11.0 +/- 2.7 pg/ml in the artery and 14.3 +/- 3.6 in the renal vein. Renal and total DA spillover rates were 0.51 +/- 0.08, 2.61 +/- 0.30 ng/min, respectively, both of which were significantly (p < 0.001) lower than the respective norepinephrine (NE) spillover rates (renal: 16.3 +/- 1.4, total: 39.6 +/- 1.7). The fractional extraction of 3H-DA across the kidney (55 +/- 3%) and the total DA clearance (285 +/- 31 ml/min) were both significantly (p < 0.05) higher than that of 3H-NE (45 +/- 3) and the total NE clearance (198 +/- 9), respectively. The ratio of renal to the total spillover rate of DA (0.23 +/- 0.05) was significantly (p < 0.05) lower than that of NE (0.41 +/- 0.04). These results demonstrate that DA is released into plasma within the kidney and suggest that the measurement of renal DA spillover rate using 3H-DA radiotracer technique is useful to detect resting renal dopaminergic nerve activity.
- Published
- 1995
- Full Text
- View/download PDF
36. Effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients.
- Author
-
Watanabe T, Noshiro T, Akama H, Kusakari T, Shibukawa S, Miura W, Abe K, and Miura Y
- Subjects
- Adult, Aldosterone blood, Dopamine blood, Epinephrine blood, Humans, Hyperaldosteronism physiopathology, Hypertension blood, Methyltyrosines, Norepinephrine blood, Tyrosine 3-Monooxygenase antagonists & inhibitors, alpha-Methyltyrosine, Dexamethasone pharmacology, Dopamine physiology, Dopamine Agents pharmacology, Hypertension physiopathology
- Abstract
To investigate the peripheral dopaminergic modulation in the pathogenesis of human hypertension, we examined the responses of plasma free dopamine (DA) to dexamethasone (Dx) administration, which is suggested to activate dopaminergic activity. We administered Dx 2 mg intravenously to patients with primary aldosteronism (PA), essential hypertension (EH), and normotensive controls (NT). Plasma free DA was increased significantly in all groups and the responses were more remarkable in PA than in EH and NT. Plasma epinephrine (E) showed a gradual increase while plasma norepinephrine (NE) tended to decrease in all groups. The responses of both plasma DA and E were completely blocked by 250 mg of alpha-methyl-p-tyrosine, a tyrosine hydroxylase (TH) inhibitor, suggesting that Dx may stimulate peripheral dopaminergic activity by increasing catecholamine synthesizing enzyme (probably TH) activities. These data suggest that DA itself plays an inherent role in the sympathoadrenal regulation rather than only as a precursor of NE and that dopaminergic hyperresponses may be involved in the pathophysiology of PA.
- Published
- 1995
- Full Text
- View/download PDF
37. Plasma free dopamine: physiological variability and pathophysiological significance.
- Author
-
Miura Y, Watanabe T, Noshiro T, Shimizu K, Kusakari T, Akama H, Shibukawa S, Miura W, Ohzeki T, and Takahashi M
- Subjects
- Dexamethasone pharmacology, Dopamine Agents pharmacology, Humans, Hypertension blood, Hypertension physiopathology, Sodium, Dietary pharmacology, Dopamine blood, Dopamine physiology
- Abstract
Dopamine (DA) is the most abundant catecholamines in human plasma and exists mostly in the sulfo-conjugated form (DA sulfate), a biologically inactive metabolite. The paucity of unconjugated DA (PDA) in plasma throws doubt on its physiological significance. However, PDA, when measured with a highly sensitive radioenzymatic method, showed quite different features from norepinephrine and epinephrine in some types of clinical hypertension, lower in essential hypertension and higher in primary aldosteronism and pheochromocytoma. There was a weak but significant correlation between the values of PDA and DA sulfate measured in the same specimens, but DA sulfate was more susceptible to impaired renal function. Upright posture, high salt diets and an intravenous injection of metoclopramide (MCP, 10 mg), a DA receptor antagonist, induced a slight but significant increase in PDA in normal and hypertensive subjects. An intravenous dexamethasone (2 mg) caused a gradual increase in PDA over 150 min after medication, which was completely blocked by concomitant administration of alpha-methyl-p-tyrosine, a tyrosine hydroxylase inhibitor. The responses of PDA to both high salt diets and MCP were blunted in salt-sensitive patients with uncomplicated essential hypertension. The results suggest that DA is not only a precursor of norepinephrine biosynthesis but also plays an inherent role as an active neurotransmitter in the peripheral sympathoadrenal system, and that PDA is a sensitive marker of peripheral dopaminergic activity, which may operate to modulate the cardiovascular and endocrine functions and participate in the pathogenesis of some types of hypertension.
- Published
- 1995
- Full Text
- View/download PDF
38. Recurrence of nanophthalmic uveal effusion.
- Author
-
Morita H, Funata M, Kusakari T, Yoshino Y, and Kiyosawa M
- Subjects
- Exudates and Transudates, Female, Humans, Middle Aged, Recurrence, Retinal Detachment etiology, Retinal Detachment surgery, Sclera surgery, Uveal Diseases pathology, Uveal Diseases surgery, Sclera abnormalities, Sclera ultrastructure, Uveal Diseases etiology
- Abstract
A patient with nanophthalmic uveal effusion had a recurrence 7 months after the initial sclerectomies and sclerostomies. The effusion was cured by repeating the procedure. Specimens obtained at the first operation showed interlacing collagen lamellae and thin collagen bundles with an electron-dense deposit in the perifibrillar space. Specimens from the second operation showed disarranged collagen bundles with closely packed thin collagen fibrils. Collagen lamellae were not found. The regenerated scleral tissue was thought to interfere with the transscleral outflow and to block the bypass route, thus resulting in the recurrence of uveal effusion.
- Published
- 1993
- Full Text
- View/download PDF
39. QT prolongation with torsade de pointes in pheochromocytoma.
- Author
-
Shimizu K, Miura Y, Meguro Y, Noshiro T, Ohzeki T, Kusakari T, Akama H, Watanabe T, Honma H, and Imai Y
- Subjects
- Female, Humans, Middle Aged, Tachycardia diagnosis, Torsades de Pointes diagnosis, Adrenal Gland Neoplasms complications, Electrocardiography, Pheochromocytoma complications, Syncope etiology, Tachycardia etiology, Torsades de Pointes etiology
- Published
- 1992
- Full Text
- View/download PDF
40. [Legislation related to the management of kidney failure].
- Author
-
Kusakari T
- Subjects
- Health Education, Humans, Japan, Tissue Banks, Kidney Failure, Chronic surgery, Kidney Transplantation, Legislation as Topic
- Published
- 1987
41. Effects of propranolol on the circulatory changes and mobilization of free fatty acids caused by isoproterenol.
- Author
-
Nakano J, Kusakari T, and Berry JL
- Subjects
- Animals, Blood Glucose analysis, Blood Pressure drug effects, Dogs, Fatty Acids, Nonesterified blood, Fatty Acids, Nonesterified metabolism, Heart Rate drug effects, Male, Fatty Acids metabolism, Isoproterenol pharmacology, Propranolol pharmacology
- Published
- 1966
42. Effect of propranolol on the peripheral circulation.
- Author
-
Nakano J and Kusakari T
- Subjects
- Animals, Atropine pharmacology, Blood Pressure drug effects, Dogs, Femoral Artery, Heart Rate drug effects, Isoproterenol pharmacology, Propranolol pharmacology, Vascular Resistance drug effects, Blood Circulation drug effects, Sympatholytics pharmacology
- Published
- 1965
- Full Text
- View/download PDF
43. COMPETITIVE ANTAGONISM BETWEEN ISOPROTERENOL AND A NEW BETA-RECEPTOR ADRENERGIC BLOCKING AGENT, PROPRANOLOL.
- Author
-
NAKANO J and KUSAKARI T
- Subjects
- Adrenergic beta-Antagonists, Blood Pressure, Blood Pressure Determination, Heart, Isoproterenol, Pharmacology, Physiology, Propranolol, Research, Sympatholytics, Vasoconstrictor Agents, Vasodilator Agents
- Published
- 1965
- Full Text
- View/download PDF
44. Effect of bradykinin and eledoisin on the regional circulation.
- Author
-
Nakano J and Kusakari T
- Subjects
- Animals, Dogs, Regional Blood Flow drug effects, Blood Circulation drug effects, Bradykinin pharmacology, Eledoisin pharmacology, Femoral Artery, Femoral Vein
- Published
- 1966
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.